More SEC Filings
View Older Stories View Newer Stories-
Form DEFA14A Immix Biopharma, Inc.
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 NXG NextGen Infrastructu
-
Form D/A Doma Perpetual LO Equity
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 CITIGROUP INC
-
Form 424B2 UBS AG
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 UBS AG
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Huffman Kyle E.
-
Form 4 MID AMERICA APARTMENT For: Apr 01 Filed by: Carpenter Melanie
-
Form 4 Total Return Securities For: Apr 02 Filed by: Dakos Andrew
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Barton Scott Winter
-
Form 144 Arqit Quantum Inc. Filed by: Leaver Andrew
-
Form DEF 14A Immix Biopharma, Inc. For: Apr 06
-
Form 424B2 UBS AG
-
Form D Sequoia Capital Growth
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 3 WD 40 CO For: Apr 06 Filed by: CLOEZ CHRISTOPHE PAUL
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 UBS AG
-
Form 8-K Diameter Credit Co For: Mar 31
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: BASOLIS ELBERT G JR
-
Form 497K ALPS ETF Trust
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Berk Frederick R.
-
Form D/A Davidson Kempner Opportu
-
Form 4 Krispy Kreme, Inc. For: Apr 02 Filed by: Suess Lori M.
-
Form 4 AIRO Group Holdings, For: Apr 06 Filed by: Uczekaj John
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4/A LINDBLAD EXPEDITIONS For: Mar 31 Filed by: Goldberg Frederick
-
Form 424B2 UBS AG
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: GOODMAN LESLIE E
-
Form 424B2 JPMORGAN CHASE & CO
-
Form N-CSR ETF Opportunities Trust For: Jan 31
-
Form 4 Krispy Kreme, Inc. For: Apr 02 Filed by: Steele Nicola
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: Josephs Glenn M.
-
Form 4 Krispy Kreme, Inc. For: Apr 02 Filed by: Holder Alison
-
Form 4 Elauwit Connection, Inc. For: Apr 02 Filed by: O'Brien David J.

